— Know what they know.
Not Investment Advice
Also trades as: 1672.HK (HKSE) · $vol 3M

ASCLF Earnings

Ascletis Pharma Inc.
1W: -13.3% 1M: -18.8% 3M: -30.7% YTD: -30.2% 1Y: -14.8% 3Y: +73.3% 5Y: +173.7%
$1.04
-0.08 (-7.14%)
 
Weekly Expected Move ±10.3%
$1 $1 $1 $1 $1
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · $1.1B mcap · 205M float · 0.0004% daily turnover · Short 81% of daily vol
Last Earnings 2026-08-31
EPS
¥-0.05 (US$-0.01)
▼ Miss -53.7%
Revenue
$4M
Est (actual pending)
Next Earnings Qtr ending 2026-12-30 · date TBD
EPS Estimate
¥-0.15 (US$-0.02)
Range: ¥-0.15 - ¥-0.15
Revenue Estimate
¥42M ($6M)
1 analysts
1 USD = 6.70 CNY

Estimate vs Actual

Earnings Surprise History

4/17
EPS Beats
4/17
Revenue Beats
24%
EPS Beat Rate
24%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2027-12-31 ¥-0.64 ¥-0.64 — ¥46,678,557 ¥46,609,705
2026-10-02 annual 2028-12-31 ¥-0.03 ¥-0.03 — ¥750,795,770 ¥749,688,327
2026-10-02 annual 2026-12-31 ¥-0.52 ¥-0.52 — ¥9,970,118 ¥9,955,412
2026-09-30 annual 2027-12-31 ¥-0.64 ¥-0.64 — ¥46,625,353 ¥46,678,557
2026-09-30 annual 2028-12-31 ¥-0.03 ¥-0.03 — ¥749,940,019 ¥750,795,770
2026-09-30 annual 2026-12-31 ¥-0.52 ¥-0.52 — ¥9,958,754 ¥9,970,118
2026-09-29 annual 2027-12-31 ¥-0.64 ¥-0.64 — ¥46,575,279 ¥46,625,353
2026-09-29 annual 2028-12-31 ¥-0.03 ¥-0.03 — ¥749,134,606 ¥749,940,019
2026-09-29 quarter 2028-12-30 ¥-0.42 ¥-0.42 — ¥1,623,457,556 ¥1,623,457,556
2026-09-29 annual 2026-12-31 ¥-0.52 ¥-0.52 — ¥9,948,059 ¥9,958,754
2026-09-28 quarter 2028-12-30 ¥-0.42 ¥-0.42 — ¥1,623,457,556 ¥1,623,457,556
2026-09-28 annual 2026-12-31 ¥-0.52 ¥-0.52 — ¥9,950,733 ¥9,948,059
2026-09-28 annual 2027-12-31 ¥-0.64 ¥-0.64 — ¥46,587,798 ¥46,575,279
2026-09-28 annual 2028-12-31 ¥-0.03 ¥-0.03 — ¥749,335,959 ¥749,134,606
2026-09-25 annual 2026-12-31 ¥-0.52 ¥-0.52 — ¥9,974,798 ¥9,950,733
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms